Is AdaptHealth (AHCO) Pricing Reflect Its Recent 72.9% One Year Share Price Jump

Simply Wall St.

Apr 21

To understand what AdaptHealth might be worth to you as an investor, it helps to separate the share price story from the underlying value story. That is what this article sets out to do. Over the past...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2629046705"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2629046705\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2629046705?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","is_english":true,"pubTime":"2026-04-21 10:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2629046705","market":"sg","top_or_hot":-1,"title":"Is AdaptHealth (AHCO) Pricing Reflect Its Recent 72.9% One Year Share Price Jump","media":"Simply Wall St.","content":"<div>\n<p>To understand what AdaptHealth might be worth to you as an investor, it helps to separate the share price story from the underlying value story. That is what this article sets out to do. Over the past...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-ahco/adapthealth/news/is-adapthealth-ahco-pricing-reflect-its-recent-729-one-year\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is AdaptHealth (AHCO) Pricing Reflect Its Recent 72.9% One Year Share Price Jump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs AdaptHealth (AHCO) Pricing Reflect Its Recent 72.9% One Year Share Price Jump\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-21 10:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-ahco/adapthealth/news/is-adapthealth-ahco-pricing-reflect-its-recent-729-one-year><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>To understand what AdaptHealth might be worth to you as an investor, it helps to separate the share price story from the underlying value story. That is what this article sets out to do. Over the past...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-ahco/adapthealth/news/is-adapthealth-ahco-pricing-reflect-its-recent-729-one-year\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AHCO","symbol_name":"AdaptHealth Corp.","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-ahco/adapthealth/news/is-adapthealth-ahco-pricing-reflect-its-recent-729-one-year","article_id":"2629046705","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-ahco/adapthealth/news/is-adapthealth-ahco-pricing-reflect-its-recent-729-one-year","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2629046705","pubTimestamp":1776737276,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"To understand what AdaptHealth might be worth to you as an investor, it helps to separate the share price story from the underlying value story. That is what this article sets out to do.\nOver the past year, the stock has recorded a 72.9% return, with returns of 2.8% over 7 days, 27.9% over 30 days, and 31.0% year to date, while the 3 year return is 4.5% and the 5 year return is a 57.0% decline, indicating a mixed longer term picture.\nRecent company developments and sector sentiment shifts...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"AHCO":"AdaptHealth Corp.","BK4175":"保健护理产品经销商","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc"},"translate_title":"AdaptHealth(AHCO)的定价是否反映了其最近一年内72.9%的股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AHCO":1.5,"DCF":1},"content_text":"To understand what AdaptHealth might be worth to you as an investor, it helps to separate the share price story from the underlying value story. That is what this article sets out to do. Over the past year, the stock has recorded a 72.9% return, with returns of 2.8% over 7 days, 27.9% over 30 days, and 31.0% year to date, while the 3 year return is 4.5% and the 5 year return is a 57.0% decline, indicating a mixed longer term picture. Recent company developments and sector sentiment shifts provide important context for these moves. This includes how investors are reacting to AdaptHealth's role in the broader healthcare space and any changes in expectations around its growth or risk profile. On Simply Wall St's valuation checks, AdaptHealth has a valuation score of 4 out of 6. This opens the door to compare different valuation methods later in this article, and to finish with a perspective on a richer way to think about value beyond a single score. AdaptHealth delivered 72.9% returns over the last year. See how this stacks up to the rest of the Healthcare industry. AdvertisementApproach 1: AdaptHealth Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow, or DCF, model estimates what a company might be worth today by projecting its future cash flows and then discounting those back to the present using a required return. For AdaptHealth, the model uses a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about $258.8 million. Analysts provide estimates out to 2027, with Simply Wall St extending those projections further. Within this framework, projected free cash flow for 2035 is $274.7 million, which is discounted back to today at $133.3 million. Intermediate years between 2026 and 2034 also contribute to the total equity value. Pulling those discounted figures together, the model arrives at an estimated intrinsic value of $36.74 per share. Compared with the current share price, this implies a 65.5% discount, which points to AdaptHealth trading materially below this DCF estimate. Result: UNDERVALUED Our Discounted Cash Flow (DCF) analysis suggests AdaptHealth is undervalued by 65.5%. Track this in your watchlist or portfolio, or discover 63 more high quality undervalued stocks. AHCO Discounted Cash Flow as at Apr 2026 Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for AdaptHealth. Approach 2: AdaptHealth Price vs Sales For companies where earnings can be uneven, the P/S ratio is often a practical yardstick because it compares the share price to the revenue the business generates, which tends to be more stable than profits. Growth expectations and risk still matter, because higher expected growth or lower perceived risk can justify a higher “normal” P/S multiple, while lower growth or higher risk often point to a lower one. AdaptHealth currently trades on a P/S ratio of 0.53x. This is below the broader Healthcare industry average of 1.20x and slightly above the peer group average of 0.47x. Simply Wall St’s proprietary Fair Ratio for AdaptHealth is 0.60x, which is an estimate of the P/S multiple that might be reasonable given factors such as its earnings growth profile, industry, profit margins, market cap and risk characteristics. The Fair Ratio aims to be more tailored than a straight comparison with peers or industry averages because it adjusts for company specific drivers like growth, risks and profitability rather than assuming all companies deserve the same multiple. Comparing the Fair Ratio of 0.60x with the current P/S of 0.53x suggests that AdaptHealth is trading below this Fair Ratio estimate. Result: UNDERVALUED NasdaqCM:AHCO P/S Ratio as at Apr 2026 P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies. Upgrade Your Decision Making: Choose your AdaptHealth Narrative Earlier it was mentioned that there is an even better way to understand valuation, so Narratives are a simple way for you to plug your view of AdaptHealth into a financial forecast, link that to a fair value, and then compare it with the current share price. On Simply Wall St's Community page, Narratives let you set assumptions for future revenue, earnings and margins, so you can capture the story you believe, whether that looks closer to a bullish fair value of US$17.0 or a more cautious US$9.50. Each Narrative turns those assumptions into an estimated fair value and continuously checks it against the live market price. This can help you decide whether AdaptHealth looks closer to a buy, a sell, or a hold for your own portfolio rules. Narratives update automatically when new news, earnings or guidance are added to the platform. For example, if you think the new US$1b plus capitated contract will drive stronger long term cash generation than the market assumes, your bullish Narrative will reflect that. Another investor might build a more cautious story that stresses reimbursement pressure and infrastructure costs, and both views can sit side by side for you to compare. For AdaptHealth however we'll make it really easy for you with previews of two leading AdaptHealth Narratives: 🐂 AdaptHealth Bull Case Fair value: US$17.00 Gap to fair value vs last close: ((17.0 - 12.67) / 17.0) = 25.5% below this bullish fair value estimate Revenue growth assumption: 7.77% per year  Analysts in this camp focus on the new US$1b plus capitated contract, ongoing acquisitions and tech enabled efficiency as potential drivers of higher revenue, margins and cash flow over time. The narrative assumes earnings turn around from a loss to US$243.2m by 2029 with profit margins moving from a 2.2% loss to a 6.0% margin, supported by a future P/E of 12.9x, below the current US Healthcare industry P/E of 22.6x. Key risks include reimbursement pressure from CMS, execution risk on large contracts, high leverage of US$1.8b net debt, and the possibility that value based care and digital health could weigh on demand or margins.  🐻 AdaptHealth Bear Case Fair value: US$9.50 Gap to fair value vs last close: ((12.67 - 9.5) / 9.5) = 33.4% above this bearish fair value estimate Revenue growth assumption: 5.41% per year  The cautious view highlights that the same large capitated contract and homecare demand also bring heavier infrastructure spending, higher operating costs and capital expenditure, which could limit free cash flow and margin improvement. This narrative assumes revenue grows more slowly, margins reach 4.4% by 2029 and earnings reach US$165.9m, with the shares on a 10.6x P/E, again below the US Healthcare industry P/E of 21.2x. Risks flagged here include CMS competitive bidding, payer consolidation, digital health potentially reducing demand for core products, and tougher reimbursement terms that could keep pressure on both revenue growth and profitability.  If you want to go beyond these previews and weigh up which story is closer to your own expectations for contracts, margins and reimbursement risk, See what the community is saying about AdaptHealth. Do you think there's more to the story for AdaptHealth? Head over to our Community to see what others are saying! NasdaqCM:AHCO 1-Year Stock Price Chart  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}